Leishmaniasis refers to a group of diseases that afflicts 12 million persons worldwide, with an estimated 2 million new infections occurring annually (1). All three forms of the disease, visceral, cutaneous and mucosal leishmaniasis, are prevalent in our study areas in the Northeast of Brazil. The main objective of this program is to strengthen and expand knowledge of the host-parasite relationship in leishmaniasis that will allow new forms of therapy and control of leishmaniasis. The Federal University of Bahia (UFBA) Tropical Medicine Research Center was established in 1991. The Federal University of Rio Grande do Norte (UFRN) joined the TMRC in 1996 to share their expertise in leishmaniasis. Strong collaborative programs have been established between Brazilian and US investigators in tropical diseases. This proposal will emphasize the application of molecular approaches to determine host (immunologic, genetic) and parasite (genetic, phenotypic) factors contributing to the pathogenesis of tegumentary and visceral leishmaniasis. New diagnostic and therapeutic approaches are the ultimate goals of this research. An increased understanding of the pathogenesis and genetics of leishmaniasis may provide the basis for innovative clinical strategies. The program has two cores (administrative, data management) and 3 scientific projects. Project I, """"""""The role of Leishmania braziliensis strain polymorphism on disease outcome and distribution"""""""" will determine the role of parasite polymorphisms in the different clinical forms associated to L. braziliensis infection and identify markers for the molecular diagnosis of leishmaniasis. Project II, """"""""Protective and Pathogenic Immune Responses in Tegumentary Leishmaniasis"""""""" will identify at molecular and cellular level immunological responses associated with protection and those responses associated with pathology in individuals with subclinical L. braziliensis infection and in patients with cutaneous and mucosal leishmaniasis. The duration of immunologic memory to soluble leishmania antigens and recombinant vaccine candidates antigens will also be evaluated in individuals with a past history of L. braziliensis or L. chagasi infection. Project III, """"""""Genetic Determinants of Leishmaniasis"""""""" will expand our knowledge of genes associated with the clinical expression of L. chagasi and L. braziliensis infection. Studies performed in theses projects will seek to identify new interventions to control and/or ameliorate leishmaniasis worldwide.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
5P50AI030639-18
Application #
7891317
Study Section
Special Emphasis Panel (ZAI1-GSM-M (J1))
Program Officer
Rao, Malla R
Project Start
1991-03-01
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
18
Fiscal Year
2010
Total Cost
$678,809
Indirect Cost
Name
Federal University of Bahia
Department
Type
DUNS #
900845397
City
Salvador
State
Country
Brazil
Zip Code
40110-160
Sousa, Rosana; Andrade, Viviane M; Bair, Thomas et al. (2018) Early Suppression of Macrophage Gene Expression by Leishmania braziliensis. Front Microbiol 9:2464
Silva, Silvana C; Guimarães, Luiz Henrique; Silva, Juliana A et al. (2018) Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients. Acta Trop 178:34-39
Teixeira, D G; Monteiro, G R G; Martins, D R A et al. (2017) Comparative analyses of whole genome sequences of Leishmania infantum isolates from humans and dogs in northeastern Brazil. Int J Parasitol 47:655-665
Lima, Josivan Gomes; Nobrega, Lucia Helena C; Lima, Natalia Nobrega et al. (2017) Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy. Bone 101:21-25
Lima, Ádila L M; de Lima, Iraci D; Coutinho, José F V et al. (2017) Changing epidemiology of visceral leishmaniasis in northeastern Brazil: a 25-year follow-up of an urban outbreak. Trans R Soc Trop Med Hyg 111:440-447
Kelly, Patrick H; Bahr, Sarah M; Serafim, Tiago D et al. (2017) The Gut Microbiome of the Vector Lutzomyia longipalpis Is Essential for Survival of Leishmania infantum. MBio 8:
Gimblet, Ciara; Meisel, Jacquelyn S; Loesche, Michael A et al. (2017) Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation. Cell Host Microbe 22:13-24.e4
Almeida, Lucas; Silva, Juliana A; Andrade, Viviane M et al. (2017) Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection. Infect Genet Evol 49:212-220
Weirather, Jason L; Duggal, Priya; Nascimento, Eliana L et al. (2017) Comprehensive candidate gene analysis for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil. Ann Hum Genet 81:41-48
Novais, Fernanda O; Carvalho, Augusto M; Clark, Megan L et al. (2017) CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1? production. PLoS Pathog 13:e1006196

Showing the most recent 10 out of 85 publications